+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal - Product Thumbnail Image

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal

  • Report
  • December 2019
  • 63 Pages
  • Global
From
Europe HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 95 Pages
  • Europe
From
Asia Pacific HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 97 Pages
  • Asia Pacific
From
North America HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 91 Pages
  • North America
From
LAMEA HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 97 Pages
  • Middle East, Africa
From
HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • March 2024
  • 143 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report and Forecast 2024-2032 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 221 Pages
  • Global
From
US HIV Market and Competitive Landscape - 2022 - Product Thumbnail Image

US HIV Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global HIV Treatment Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global HIV Treatment Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • February 2024
  • 226 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • August 2022
  • 95 Pages
  • Global
From
Cenicriviroc (Allergan/Takeda) Drug Overview 2019 - Product Thumbnail Image

Cenicriviroc (Allergan/Takeda) Drug Overview 2019

  • Report
  • July 2019
  • 14 Pages
  • Global
Reyataz (atazanavir; Bristol-Myers Squibb) Drug Overview 2019 - Product Thumbnail Image

Reyataz (atazanavir; Bristol-Myers Squibb) Drug Overview 2019

  • Report
  • June 2019
  • 18 Pages
  • Global
Viread - API Insight, 2022 - Product Thumbnail Image

Viread - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Sustiva - API Insight, 2022 - Product Thumbnail Image

Sustiva - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Norvir SEC - API Insight, 2022 - Product Thumbnail Image

Norvir SEC - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Kaletra - API Insight, 2022 - Product Thumbnail Image

Kaletra - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Isentress - API Insight, 2022 - Product Thumbnail Image

Isentress - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Selzentry - API Insight, 2022 - Product Thumbnail Image

Selzentry - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Truvada - API Insight, 2022 - Product Thumbnail Image

Truvada - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more